AIMS/HYPOTHESIS: Sugar has been suggested to promote obesity, diabetes and coronary heart disease (CHD), yet fruit, despite containing sugars, may also have a low glycaemic index (GI) and all fruits are generally recommended for good health. We therefore assessed the effect of fruit with special emphasis on low GI fruit intake in type 2 diabetes. METHODS: This secondary analysis involved 152 type 2 diabetic participants treated with glucose-lowering agents who completed either 6 months of high fibre or low GI dietary advice, including fruit advice, in a parallel design. RESULTS: Change in low GI fruit intake ranged from -3.1 to 2.7 servings/day. The increase in low GI fruit intake significantly predicted reductions in HbA(1c) (r = -0.206, p =0.011), systolic blood pressure (r = -0.183, p = 0.024) and CHD risk (r = -0.213, p = 0.008). Change in total fruit intake ranged from -3.7 to 3.2 servings/day and was not related to study outcomes. In a regression analysis including the eight major carbohydrate foods or classes of foods emphasised in the low GI diet, only low GI fruit and bread contributed independently and significantly to predicting change in HbA(1c). Furthermore, comparing the highest with the lowest quartile of low GI fruit intake, the percentage change in HbA(1c) was reduced by -0.5% HbA(1c) units (95% CI 0.2-0.8 HbA(1c) units, p < 0.001). CONCLUSIONS/ INTERPRETATION: Low GI fruit consumption as part of a low GI diet was associated with lower HbA(1c), blood pressure and CHD risk and supports a role for low GI fruit consumption in the management of type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00438698.
RCT Entities:
AIMS/HYPOTHESIS: Sugar has been suggested to promote obesity, diabetes and coronary heart disease (CHD), yet fruit, despite containing sugars, may also have a low glycaemic index (GI) and all fruits are generally recommended for good health. We therefore assessed the effect of fruit with special emphasis on low GI fruit intake in type 2 diabetes. METHODS: This secondary analysis involved 152 type 2 diabeticparticipants treated with glucose-lowering agents who completed either 6 months of high fibre or low GI dietary advice, including fruit advice, in a parallel design. RESULTS: Change in low GI fruit intake ranged from -3.1 to 2.7 servings/day. The increase in low GI fruit intake significantly predicted reductions in HbA(1c) (r = -0.206, p =0.011), systolic blood pressure (r = -0.183, p = 0.024) and CHD risk (r = -0.213, p = 0.008). Change in total fruit intake ranged from -3.7 to 3.2 servings/day and was not related to study outcomes. In a regression analysis including the eight major carbohydrate foods or classes of foods emphasised in the low GI diet, only low GI fruit and bread contributed independently and significantly to predicting change in HbA(1c). Furthermore, comparing the highest with the lowest quartile of low GI fruit intake, the percentage change in HbA(1c) was reduced by -0.5% HbA(1c) units (95% CI 0.2-0.8 HbA(1c) units, p < 0.001). CONCLUSIONS/ INTERPRETATION:Low GI fruit consumption as part of a low GI diet was associated with lower HbA(1c), blood pressure and CHD risk and supports a role for low GI fruit consumption in the management of type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00438698.
Authors: Teresa T Fung; Meir J Stampfer; JoAnn E Manson; Kathryn M Rexrode; Walter C Willett; Frank B Hu Journal: Stroke Date: 2004-07-01 Impact factor: 7.914
Authors: Kimber L Stanhope; Steven C Griffen; Brandi R Bair; Michael M Swarbrick; Nancy L Keim; Peter J Havel Journal: Am J Clin Nutr Date: 2008-05 Impact factor: 7.045
Authors: Shirley A A Beresford; Karen C Johnson; Cheryl Ritenbaugh; Norman L Lasser; Linda G Snetselaar; Henry R Black; Garnet L Anderson; Annlouise R Assaf; Tamsen Bassford; Deborah Bowen; Robert L Brunner; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Margery Gass; Rosanne C Harrigan; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Jane Morley Kotchen; Lewis H Kuller; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Cora E Lewis; JoAnn E Manson; Karen L Margolis; Yasmin Mossavar-Rahmani; Judith K Ockene; Linda M Parker; Michael G Perri; Lawrence Phillips; Ross L Prentice; John Robbins; Jacques E Rossouw; Gloria E Sarto; Marcia L Stefanick; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Evelyn Whitlock Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: Barbara V Howard; Linda Van Horn; Judith Hsia; JoAnn E Manson; Marcia L Stefanick; Sylvia Wassertheil-Smoller; Lewis H Kuller; Andrea Z LaCroix; Robert D Langer; Norman L Lasser; Cora E Lewis; Marian C Limacher; Karen L Margolis; W Jerry Mysiw; Judith K Ockene; Linda M Parker; Michael G Perri; Lawrence Phillips; Ross L Prentice; John Robbins; Jacques E Rossouw; Gloria E Sarto; Irwin J Schatz; Linda G Snetselaar; Victor J Stevens; Lesley F Tinker; Maurizio Trevisan; Mara Z Vitolins; Garnet L Anderson; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Margery Gass; Iris Granek; Philip Greenland; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; F Allan Hubbell; Karen C Johnson; Jane Morley Kotchen Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: John P Pierce; Loki Natarajan; Bette J Caan; Barbara A Parker; E Robert Greenberg; Shirley W Flatt; Cheryl L Rock; Sheila Kealey; Wael K Al-Delaimy; Wayne A Bardwell; Robert W Carlson; Jennifer A Emond; Susan Faerber; Ellen B Gold; Richard A Hajek; Kathryn Hollenbach; Lovell A Jones; Njeri Karanja; Lisa Madlensky; James Marshall; Vicky A Newman; Cheryl Ritenbaugh; Cynthia A Thomson; Linda Wasserman; Marcia L Stefanick Journal: JAMA Date: 2007-07-18 Impact factor: 56.272
Authors: Vanessa Ha; Viranda H Jayalath; Adrian I Cozma; Arash Mirrahimi; Russell J de Souza; John L Sievenpiper Journal: Curr Hypertens Rep Date: 2013-08 Impact factor: 5.369
Authors: Daniel J Cox; Ann Gill Taylor; Elizabeth S Dunning; Mary C Winston; Ingrid L Luk Van; Anthony McCall; Harsimran Singh; William S Yancy Journal: Curr Diab Rep Date: 2013-12 Impact factor: 4.810